Breeze Bio
Latest round
- Series B
Last raised
- Feb 2026
Total raised
- $125M
Investors
- 32
About Breeze Bio
Breeze Bio, Inc. formerly known as GenEdit is a biotechnology company founded in 2016 and based in California, US. The company develops the NanoGalaxy platform, an in vivo genetic medicine delivery system that uses proprietary non-lipid, hydrophilic polymer nanoparticles to enable targeted delivery of nucleic acid therapeutics beyond the liver. Breeze Bio was co-founded by Kunwoo Lee, who serves as CEO, and Hyo Min Park, who serves as COO. In February 2026, Breeze Bio, Inc.
Who invested in Breeze Bio
32 investors across 7 rounds
See all investors in Breeze Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Feb 25, 2026
Amount
$34M
Investors
Series B
Nov 20, 2024
Amount
$3.4M
Investors
Series A
Jan 23, 2024
Amount
$24M
Investors
Series A
Feb 1, 2023
Amount
$3M
Investors
Series A
Sep 23, 2021
Amount
$26M
Investors
Series A
Nov 12, 2020
Amount
$26M
Investors
Seed
Nov 16, 2018
Amount
$8.6M
Investors
Questions about Breeze Bio
Who invested in Breeze Bio?
Breeze Bio has 32 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Breeze Bio raised?
Breeze Bio has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Breeze Bio last raise money?
Breeze Bio's most recent round on record is a Series B, in Feb 2026.
What does Breeze Bio do?
Breeze Bio is a biotechnology company.
Where is Breeze Bio headquartered?
Breeze Bio is headquartered in Brisbane, US.
Which VCs invest in companies like Breeze Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Breeze Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Breeze Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.